403. The Potential of Pro-Apoptotic PAC-1 Treatment for Augmentation of IL-2 Mediated Breast Cancer Immunotherapy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34738-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV